Anticholinergic
https://en.wikipedia.org/wiki/Anticholinergic
Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. (March 2015). "Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study". JAMA Internal Medicine. 175 (3): 401–407. doi:10.1001/jamainternmed.2014.7663. PMC 4358759. PMID 25621434.
Fox, C; Smith, T; Maidment, I; Chan, WY; Bua, N; Myint, PK; Boustani, M; Kwok, CS; Glover, M; Koopmans, I; Campbell, N (September 2014). "Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review". Age and Ageing. 43 (5): 604–15. doi:10.1093/ageing/afu096. PMID 25038833.
Andre, L; Gallini, A; Montastruc, F; Montastruc, JL; Piau, A; Lapeyre-Mestre, M; Gardette, V (29 August 2019). "Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review". European Journal of Clinical Pharmacology. 75 (12): 1631–1644. doi:10.1007/s00228-019-02744-8. PMID 31468067. S2CID 201675824.
Ruxton, K; Woodman, RJ; Mangoni, AA (2 March 2015). "Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis". British Journal of Clinical Pharmacology. 80 (2): 209–20.
Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. (March 2015). "Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study". JAMA Internal Medicine. 175 (3): 401–407. doi:10.1001/jamainternmed.2014.7663. PMC 4358759. PMID 25621434.
Talan, Jamie (July–August 2008). "Common Drugs May Cause Cognitive Problems". Neurology Now. 4 (4): 10–11. doi:10.1097/01.NNN.0000333835.93556.d1. Archived from the original on 2019-06-26. Retrieved 26 June 2019.
anticholinergic cognitive burden scale
https://www.health.harvard.edu/newsletter_article/anticholinergic-cognitive-burden-scale
https://www.sciencedirect.com/science/article/pii/S0167494319301207
The remaining six scales met all criteria and thus proceeded to full review: Anticholinergic Activity Scale (AAS) (Ehrt, Broich, & Larsen, 2010); Anticholinergic Burden Classification (ABC) scale (Ancelin, Artero, & Portet, 2006); Anticholinergic Cognitive Burden (ACB) scale (Boustani et al., 2008b); Anticholinergic Drug Scale (ADS) (Carnahan, Lund, & Perry, 2006); Anticholinergic Loading Scale (ALS) (Sittironnarit, Ames, & Bush, 2011); and the Anticholinergic Risk Scale (ARS) (Rudolph, Salow, & Angelini, 2008).
https://insightplus.mja.com.au/2019/17/troubled-reality-of-anticholinergic-burden-scales/
The Beers criteria
The Screening Tool of Older Person's Prescriptions (STOPP) criteria
http://www.acbcalc.com/pages/about
Complete References:
1. Boustani MA, Campbell NL, Munger S, Maidment I, Fox GC. Impact of anticholinergics on the aging brain: a review and practical application. Aging Heatlh. 2008;4(3):311-320.
2. Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clinical Interventions in Aging. 2009;4(1):225-233.
3. Campbell N, Boustani M, Lane K, et al. Use of anticholinergics and the risk of cognitive impairment in an AfricanAmerican population. Neurology. 2010;75:152-159.
4. Fox C, Richardson K, Maidment I, et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Cognitive Function and Ageing Study. Journal of the American Geriatric Society. 2011; 59(8): 1477-1483.
5. Cai X, Campbell N, Khan B, Callahan C, Boustani M. Long-term anticholinergic use and the aging brain. Alzheimers Dementia. 2012;
anticholinergic cognitive burden scale
https://corumpharmacy.com/wp-content/uploads/2020/08/Anticholinergic-cognitive-burden-scale.pdf
https://gmedss.com/about